Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1327
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1421 | Human il-6 Protein, HEK (AC1421) | 2 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
| ACPP-1022 | Recombinant Human Integrin beta 1 Protein (Fc Tag) (AC1022) | 50 µg | inquiry |
| ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
| ACPP-1118 | Human Insulin (Active) (AC1118) | 25 mg | inquiry |
| ACPP-1769 | Human VAT1 Protein (AC1769) | 2 µg | inquiry |
| ACPP-1642 | ENPP2 Blocking Peptide (AC1642) | 250 µg | inquiry |
| ACPP-1645 | Human FAM84B Protein (AC1645) | 5 µg | inquiry |
| ACPP-1122 | Synthetic Membrane Nanoparticle Human Adenosine Receptor A2a Protein (AC1122) | 50 µg | inquiry |
| ACPP-1016 | Synthetic Nanodisc Human GnRHR Protein (AC1016) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.